Kratom is derived from the natural leaf of Mitragyna speciosa and contains a full-spectrum mix of alkaloids, whereas 7-hydroxymitragynine (7-OH) is a single alkaloid present in trace amounts or used in concentrated forms. This difference in source and composition directly impacts potency, as kratom delivers moderate, dose-dependent effects, while 7-OH shows higher activity on a milligram basis due to stronger receptor interaction.
When comparing their practical use and real-world application, these differences extend to product forms and effects, with kratom available as powder, capsules, and tea, whereas 7-OH appears in tablets, syrups, and extracts. As a result, side effects and dependence patterns differ, with kratom linked to gradual tolerance, while 7-OH shows faster tolerance and stronger withdrawal.
From a legal perspective, kratom is not federally banned but regulated by the state, whereas 7-OH exists in a more uncertain regulatory space. At the federal level, 7-OH remains unscheduled but under FDA scrutiny, and state-by-state laws continue to evolve. Overall, 7-OH is generally considered more habit-forming than kratom, reflecting its concentrated pharmacological profile.
What is Kratom?
Kratom is a natural botanical substance derived from the leaves of Mitragyna speciosa, a tropical tree native to Southeast Asia, including Thailand, Indonesia, and Malaysia. The kratom leaf contains active alkaloids, primarily mitragynine, which makes up most of its alkaloid content, and 7-hydroxymitragynine (7-OH) in trace amounts. These alkaloids interact with mu opioid receptors, influencing the overall kratom experience. At lower amounts, kratom may produce stimulating effects, while higher amounts can lead to more sedating and analgesic effects depending on dose and alkaloid composition.
What is 7-Hydroxymitragynine (7-OH)?
7-Hydroxymitragynine (7-OH) is a terpenoid indole alkaloid present in trace amounts in the kratom leaf and also forms as an active metabolite of mitragynine during metabolism. Most commercially available 7-OH is lab-produced or isolated, rather than obtained directly from raw kratom leaf in meaningful quantities. It interacts with mu opioid receptors, which play a key role in regulating pain perception and mood, contributing to its analgesic and sedative effects. Due to this interaction profile, it is often considered more potent than mitragynine, with stronger receptor binding and faster onset of effects. It is commonly available in various formulations such as tablets, capsules, syrups, and concentrated extracts, allowing different methods of consumption based on use and dosage requirements.
What is the Difference Between Kratom and 7-Hydroxymitragynine?
Kratom is associated with dose-dependent effects that range from stimulation to sedation due to its full-spectrum alkaloid content, whereas 7-hydroxymitragynine (7-OH) is associated with more concentrated and receptor-focused effects. Kratom may promote energy and alertness at lower amounts or relaxation at higher amounts, whereas 7-hydroxy is typically linked to more pronounced analgesic and sedating effects at smaller concentrations. This difference results from their distinct compositions: kratom contains multiple interacting alkaloids, whereas 7-OH is a single, concentrated alkaloid with a different pharmacological profile.
Below are the key differences between Kratom and 7-Hydroxymitragynine
| Attributes | Kratom | 7-Hydroxymitragynine (7-OH) |
| Source & Composition | Derived from natural kratom leaf (Mitragyna speciosa) with full-spectrum alkaloids (mitragynine dominant, trace 7-OH) | Isolated or lab-produced alkaloid, present only in trace amounts in raw kratom |
| Potency | Milder, balanced by total alkaloid content | More concentrated with a higher receptor interaction profile |
| Product Forms | Powder, capsules, tea, extracts, enhanced kratom products | Tablets, capsules, syrups, extract shots, alkaloid formulations |
| Effects | Stimulating or sedating (dose-based) | More focused, often sedating |
| Risk and Side Effects | Nausea, dizziness, constipation, dependence with heavy use | Higher tolerance, withdrawal risk |
| Legal Status | Not federally banned in the U.S, but restricted in some states | Legal gray area |
Source & Composition
Kratom is derived from Mitragyna speciosa, a tree native to Southeast Asia, whereas 7-hydroxymitragynine (7-OH) occurs in trace amounts in the Kratom leaf and is often produced from mitragynine. Kratom contains a complex mixture of alkaloids, including mitragynine, speciogynine, speciociliatine, and paynantheine, along with other plant compounds, whereas 7-OH is a single alkaloid formed both naturally and through metabolism (CYP3A4) in the body. In terms of composition, kratom shows biphasic behaviour influenced by multiple interacting compounds, whereas 7-hydroxy acts as a receptor-focused compound with a more concentrated pharmacological profile and higher associated risk.
Potency
In terms of potency, kratom shows moderate, dose-dependent strength due to its full-spectrum alkaloid content, whereas 7-OH shows a more concentrated potency profile as a single alkaloid with stronger interaction at mu opioid receptors. Kratom’s effects are moderated by its total alkaloid matrix and typically develop gradually, while 7-OH exhibits higher receptor activity on a milligram basis, which contributes to more pronounced pharmacological effects. This difference in potency means kratom delivers broader, buffered effects, whereas 7-OH is associated with a higher intensity profile and increased risk of tolerance and dependence.
Product Forms
Kratom is commonly available as powder, capsules, tea, and extracts, whereas 7-OH is typically sold as tablets, capsules, syrups, and concentrated extract products. Kratom powder is often mixed with water or brewed into tea, while kratom capsules are swallowed for convenience. Extracts are consumed in smaller amounts due to higher concentration. In contrast, 7-hydroxy tablets or capsules are swallowed directly with water, while syrups and shots are consumed orally in liquid form for faster absorption, and gummies or candies are chewed before swallowing. Each form differs in onset, concentration, and dosing control, with 7-OH products generally offering higher concentration in smaller volumes.
Effects
When considering the effects profile, kratom is associated with dose-dependent effects that may range from stimulation to sedation, whereas 7-OH is primarily linked to more concentrated, opioid-like effects due to its isolated alkaloid nature. At lower amounts, kratom may promote alertness, focus, and physical energy, while higher amounts are more often connected with relaxation and pain relief. In comparison, 7-OH typically produces more pronounced effects such as analgesia, sedation, and euphoria even at smaller concentrations, whereas kratom’s effects vary more noticeably with dosage and its full-spectrum alkaloid composition.
Risks and Side Effects
Regarding risks and side effects, kratom is associated with nausea, dizziness, constipation, potential liver-related concerns, and withdrawal symptoms with heavy use, whereas 7-OH is linked to a higher-risk profile due to its concentrated potency and stronger interaction at mu opioid receptors. In addition, concentrated 7-hydroxy products may carry risks related to lab adulteration, which raises additional safety and regulatory concerns. These differences highlight the importance of dosage control, product quality, and informed use to reduce potential health risks and ensure safer consumption.
Legal Status
For legal status, kratom is associated with a defined but evolving regulatory framework, whereas 7-hydroxymitragynine (7-OH) exists in a more legally ambiguous position due to its concentrated alkaloid form. In the United States, kratom is not federally banned but has faced FDA scrutiny, and its legality varies by state and local jurisdiction. In comparison, 7-OH is not specifically scheduled at the federal level but is increasingly subject to regulatory concern, with some states moving to restrict or classify it separately. These differences mean that 7-OH’s legal status remains less clearly defined, and both kratom and 7-hydroxy laws are subject to ongoing changes across states.
Which is More Addictive: 7-Hydroxymitragynine or Mitragynine?
7-Hydroxymitragynine is considered more addictive than kratom due to its strong interaction with mu opioid receptors and significantly higher potency, estimating it to be multiple times more potent than morphine and far stronger than mitragynine. This high receptor activity can lead to rapid tolerance buildup and faster onset of dependence, sometimes within a short period of repeated use. In comparison, kratom mitragynine is associated with slower tolerance and milder withdrawal, whereas 7-hydroxy presents a more intense addiction and withdrawal profile.
According to a Michigan Medicine study titled “Life-destroying addiction can start at a corner store,” 7-hydroxymitragynine (7-OH), which is often produced in a lab rather than directly from the kratom plant, may be significantly more potent and more habit-forming than mitragynine, the primary active alkaloid in kratom.
Is 7-Hydroxymitragynine Legal in the US?
No,7-Hydroxymitragynine is not legal in the US, but it exists in a legal gray area, with concerns raised by the DEA and FDA. Federal agencies such as the DEA and FDA have raised concerns about kratom alkaloids, including 7-OH, particularly due to their interaction with mu opioid receptors and potential for misuse.
Federal Status
As of April 2026, 7-hydroxymitragynine (7-OH) remains unscheduled under the federal Controlled Substances Act, meaning it is not officially banned at the federal level. However, it is under significant federal scrutiny. In July 2025, the FDA recommended that the DEA classify concentrated and semi-synthetic 7-OH as a Schedule I substance due to its opioid-like profile and abuse potential.
According to the US Food and Drug Administration report, “FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers,” the FDA issued warning letters in June 2025 to seven companies for illegally distributing products containing 7-OH, including tablets, gummies, drink mixes, and shots.
State-by-State Overview
Kratom legality varies across U.S. states through bans or the Kratom Consumer Protection Act (KCPA regulation, while 7-OH faces emerging, state-specific restrictions, creating a shifting and complex legal landscape. Because laws continue to evolve, users should verify current regulations in their specific state before purchasing or using these products.
States in the US where 7-OH is Banned
- Alabama
- Arkansas
- California
- Connecticut
- Florida
- Indiana
- Kentucky
- Louisiana
- Ohio
- Rhode Island
- Vermont
- Wisconsin
States in the US where 7-OH is Legal (Regulated by KCPA)
The Kratom Consumer Protection Act (KCPA) generally allows 7-OH only as a natural byproduct of the plant. These states use “Caps” (concentration limits) to make high-potency 7-OH tablets and shots illegal.
- Arizona (7-OH capped at <2%; synthetic 7-OH banned)
- Colorado (7-OH capped at ≤2%)
- Georgia (Capped at 0.5 mg of 7-OH per gram)
- Illinois (Capped and regulated; some local bans apply)
- Maryland (Capped at 2%)
- Mississippi (Capped at 2%; numerous local city/county bans exist)
- Oklahoma (Capped at 1%)
- South Carolina (Capped at 2%)
- Texas (Capped at 2%; synthetic 7-OH banned)
- Utah (Capped at 2% of total alkaloids)
- Virginia (Capped at 2%; synthetic 7-OH banned)
- West Virginia (Capped at 2%)
States in the US where 7-OH is Legal / Unregulated
- Alaska
- Delaware
- Hawaii
- Idaho
- Maine
- Michigan
- Minnesota
- Missouri
- Montana
- Nebraska
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Oregon
- Pennsylvania
- South Carolina
- South Dakota
- Tennessee
- Wyoming
Frequently Asked Questions
Is 7-OH the same as kratom?
No, 7-OH is not the same as kratom, although it is derived from it. 7-OH is a single potent alkaloid present in trace amounts in the kratom leaf, whereas kratom is the whole plant material that contains a complex mix of multiple active compounds. This distinction means kratom delivers a broader, full-spectrum effect, while 7 hydroxy represents a more concentrated and specific component of that profile.
How much stronger is 7-OH than kratom?
7-Hydroxymitragynine (7-OH) is significantly more potent than traditional kratom, 5 to 50 times more potent than conventional kratom products. Kratom typically contains less than 2% 7-hydroxymitragynine, concentrated 7-OH products deliver substantially higher levels of this alkaloid, making them many times more potent than standard kratom powder or capsules on a milligram basis.
Is kratom legal in the United States?
Kratom is not federally banned in the United States, meaning it remains legal at the federal level. However, its legality varies by state and local jurisdiction, with some states and cities imposing bans or restrictions.
Is 7-hydroxymitragynine legal?
7-hydroxymitragynine (7-OH) is not currently scheduled as a controlled substance at the federal level in the United States, but it exists in a legal grey area.
Federal agencies, including the FDA and DEA, have raised concerns, and the FDA considers 7 hydroxy an unapproved drug and not lawful in dietary supplements or food products.
